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Abstract: Ischemia/reperfusion (I/R) injury unavoidably occurs during hepatic resection and trans-
plantation. Aged livers poorly tolerate I/R during surgical treatment. Although livers have a
powerful endogenous inhibitor of calpains, calpastatin (CAST), I/R activates calpains, leading to
impaired autophagy, mitochondrial dysfunction, and hepatocyte death. It is unknown how I/R in
aged livers affects CAST. Human and mouse liver biopsies at different ages were collected during
in vivo I/R. Hepatocytes were isolated from 3-month- (young) and 26-month-old (aged) mice, and
challenged with short in vitro simulated I/R. Cell death, protein expression, autophagy, and mito-
chondrial permeability transition (MPT) between the two age groups were compared. Adenoviral
vector was used to overexpress CAST. Significant cell death was observed only in reperfused aged
hepatocytes. Before the commencement of ischemia, CAST expression in aged human and mouse
livers and mouse hepatocytes was markedly greater than that in young counterparts. However, reper-
fusion substantially decreased CAST in aged human and mouse livers. In hepatocytes, reperfusion
rapidly depleted aged cells of CAST, cleaved autophagy-related protein 5 (ATG5), and induced de-
fective autophagy and MPT onset, all of which were blocked by CAST overexpression. Furthermore,
mitochondrial morphology was shifted toward an elongated shape with CAST overexpression. In
conclusion, CAST in aged livers is intrinsically short-lived and lost after short I/R. CAST depletion
contributes to age-dependent liver injury after I/R.
Keywords: liver; ischemia/reperfusion; autophagy; mitochondria; calpastatin
1. Introduction
Life expectancy has markedly increased over the past century and is projected to
continue to increase. Extended life span is accompanied by more aging-mediated comor-
bidities, resulting in the steady growth of elderly patients who need surgery. More than half
of the population over the age of 65 are estimated to receive surgical treatments once in their
lives [1]. Generally, deficits in hepatic morphology and function with advancing age are less
apparent clinically than in other organs. However, livers from elderly patients have poorer
recovery from surgical stress during liver resection and transplantation, signifying reduced
reparative capacity with aging [2–5]. The liver is innately vulnerable to hypoxic and anoxic
stress, especially in pericentral regions. A temporary cessation and subsequent resumption
of hepatic blood supply during liver surgery inevitably induce ischemia/reperfusion (I/R)
injury. Mechanisms behind hepatic I/R injury are multifactorial, including overproduction
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of reactive oxygen species (ROS) and nitrogen species, Ca2+ deregulation, loss of cellular
antioxidants, stimulation of catabolic enzymes, impaired autophagy, and mitochondrial
dysfunction, all of which happen during the early phase of reperfusion [6]. Moreover, these
early incidents incite hepatic inflammation during the late phase of reperfusion.
The onset of mitochondrial permeability transition (MPT) is a hallmark of mitochon-
drial dysfunction that develops soon after reperfusion [7]. Once high-conductance perme-
ability transition pores open in mitochondrial inner membranes, mitochondrial oxidative
phosphorylation uncouples and bioenergetic failure is followed [7–10]. We have demon-
strated that timely clearance of dysfunctional mitochondria through autophagy, a cellular
process eliminating abnormal cellular constituents and organelles [4], is indispensable
for hepatocyte survival after I/R [2,11]. Besides mitochondrial autophagy (mitophagy),
mitochondrial quality is also controlled by adaptive morphological changes in mitochon-
dria, a phenomenon termed mitochondrial dynamics (MD) [12]. Under non-lethal stresses,
healthy mitochondrion rapidly fuses with abnormal mitochondrion to compensate for
defects of the latter, implicating that mitochondrial interconnection serves as the first line of
defense against acute stress [13]. When abnormal mitochondria escape this fusion process,
mitophagy removes them later [14]. Hence, MD and mitophagy synergistically control the
mitochondrial quality.
Therapeutic strategies aiming at the downstream events to the MPT likely provide
only temporary relief as the opening of mitochondrial pores still prevails upon reperfusion.
Significant and persistent levels of cytoprotection against I/R injury would be achieved
by blocking cellular abnormalities upstream to the MPT. One event provoking MPT onset
after I/R is Ca2+ overload [11,15,16]. Importantly, the unrestricted elevation of Ca2+ stim-
ulates calpains. The uncontrolled activation of calpains causes irreversible tissue injury
by hydrolyzing substrates essential to cell survival, including autophagy proteins [17,18].
Nonetheless, under non-disease conditions, over-stimulation of calpains rarely occurs
due to the presence of calpastatin (CAST), an endogenous calpain-specific inhibitor [19].
Questions, hence, arise as to how calpains could be stimulated after I/R, even though the
liver has such a powerful endogenous inhibitor of calpains. It is currently unknown how
I/R affects CAST in aged livers.
Here, using human and mouse livers and hepatocytes, we show that CAST in aged
livers is intrinsically short-lived and is rapidly depleted after I/R, thereby leading to
the stimulation of calpains, cleavage of autophagy-related protein 5 (ATG5), impaired
autophagy, MPT onset, and ultimately hepatocyte death. Additionally, we uncover a new
role of CAST in the regulation of mitochondrial shape.
2. Materials and Methods
2.1. Reagents
Tetramethylrhodamine methylester (TMRM), calcein/AM, rhodamine-123 (Rd-123),
and propidium iodide (PI) were purchased from ThermoFisher Scientific (Pittsburgh, PA,
USA). Embedding agents for transmission electron microscopy were purchased from
Electron Microscopy Sciences (Hatfield, PA, USA). All other chemicals were purchased
from Millipore Sigma (St. Louise, MO, USA) except if noted otherwise.
2.2. Human Liver Biopsy Collection
Human liver biopsies were collected from the patients undergoing hepatic resection
surgery in accordance with the protocol reviewed and approved by the Institutional Review
Board of the University of Florida (201400182) and the Washington University in St. Louis
(201902153). Twelve adult patients diagnosed with hepatocellular cancer were included in
the present study (Supplemental Table S1).
2.3. Hepatocyte Isolation and Culture
To compare the similarities and differences in response to I/R between human and ro-
dent livers, mouse livers and hepatocytes were subjected to I/R. Animals received humane
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care according to the protocols approved by the Institutional Care and Use Committee of
the University of Florida (201202396) and Washington University in St. Louis (20190005).
Three-month-old male C57BL/6 J mice were purchased from the Jackson Laboratory (Bar
Harbor, ME, USA) and were fed a standard chow with free access to water. Some mice were
housed in the animal facility until they reached the age of twenty-six months old. Mouse
primary hepatocytes were isolated by a two-step collagenase perfusion method as previ-
ously described and cultured overnight in Waymouth’s medium containing 100 units/mL
penicillin, 100 g/mL streptomycin, 10% fetal bovine serum, 100 nM insulin, and 100 nM
dexamethasone [11]. Cell viability was determined by trypan blue exclusion assay and
was routinely greater than 85%. For the cell death assay, hepatocytes at a concentration
of 1.4 × 105 cells were plated onto 24-well microtiter plates (Falcon, Lincoln Park, NJ,
USA). For immunoblot and subcellular fractionation analysis, hepatocytes were plated on
35 mm and 100 mm culture dishes at a concentration of 106 and 3.5 × 106 cells, respec-
tively. For confocal microscopic studies, 2 × 105 hepatocytes were cultured on 42 mm
round glass coverslips in 60 mm culture dishes. All plates, dishes, and coverslips were
coated with 0.1% Type 1 rat tail collagen. Hepatocytes were used after overnight culture in
humidified 5% CO2 incubator at 37 ◦C. Experiments were performed in Krebs-Ringer- N-2
hydroxyethylpiperazine-N-2 ethanesulfonic acid buffer (KRH).
2.4. In Vitro Simulated I/R in Mouse Hepatocytes
Anoxia, nutrient depletion, and acidosis during ischemia were simulated by incubat-
ing hepatocytes in KRH at pH 6.2 in the anaerobic chamber (Coy Laboratory Products, Ann
Arbor, MI, USA) [2,11]. After 2 h of ischemia, the anaerobic KRH at pH 6.2 was replaced
with aerobic KRH at pH 7.4 to simulate reperfusion.
2.5. Adenoviral Infection
Some hepatocytes and livers were infected with an adenovirus expressing CAST-CFP
(with a cytomegalovirus promoter) (Welgen inc, Worcester, MA, USA) in a hormonally
defined medium as described previously [2,11]. An adenovirus harboring CFP (with a
cytomegalovirus promoter) was used as a viral control. For the liver-specific delivery
of CAST, some mice were infected with an adenoviral vector harboring CAST with α1-
antitrypsin promoter (10 µL of 1012 viral particles/mL).
2.6. Cell Death Assay
Hepatocyte death was assessed by PI fluorometry using a fluorescence plate reader
(SpectraMax M2 or iD3; Molecular device, Sunnyvale, CA, USA), as described previously [2,11].
2.7. Autophagic Flux Measurement
To measure autophagic flux, hepatocytes were treated with 20 µM chloroquine (CQ),
as described previously [20]. Changes in microtubule-associated protein light chain 3 (LC3)
expression were monitored by immunoblot analysis in the presence or absence of CQ.
2.8. Immunoblot Analysis
Changes in protein expression were determined with immunoblot analysis as de-
scribed previously [20]. Briefly, cell and tissue lysates were prepared in a radioimmunopre-
cipitation assay buffer with a protease/phosphatase inhibitor cocktail (Millipore Sigma).
The protein concentration of lysates was determined with the bicinchoninic acid pro-
tein quantification kit (Thermo Fisher Scientific, Waltham, MA, USA). Protein samples of
8–22.5 µg were electrophoresed in 8–15% gradient polyacrylamide gels and transferred elec-
trophoretically to a polyvinylidene fluoride membrane (Thermo Fisher Scientific, Waltham,
MA, USA) or nitrocellulose membranes (GE Healthcare Life Sciences, Buckinghamshire,
UK). Membranes were blocked in 5% nonfat milk and probed with primary antibodies
including CAST (#4146, Cell Signaling Technology, Danvers, MA, USA), LC3-I/II (#2775,
Cell Signaling Technology, Danvers, MA, USA), ATG12 (#4180, Cell Signaling Technology,
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Danvers, MA, USA), ATG5 (#A0856, Millipore Sigma), COX IV (#4844, Cell Signaling
Technology, Danvers, MA, USA), VDAC (#4661, Cell Signaling Technology, Danvers, MA,
USA), α-Tubulin (#sc-8035, Santa Cruz Biotechnology, Dallas, TX, USA), Lamin B1 (#9087,
Cell Signaling Technology, Danvers, MA, USA), TNFα (#17590-1-AP, Proteintech, Rose-
mont, IL, USA), and β–actin (#A5441, Millipore Sigma). After incubating with appropriate
horseradish peroxidase-conjugated secondary antibodies, specific protein bands were visu-
alized using a Bio-Rad ChemiDoc MP trans-illuminator (Bio-Rad Life Sciences, Hercules,
CA, USA). Protein expression was densitometrically quantified using IMAGE J software
(NIH, Bethesda, MD, USA) and normalized to β–actin.
2.9. In Vivo I/R
Hepatic ischemia in male C57BL/6 J mice was induced by occluding the portal triad for
30 min, as previously described [2]. Reperfusion was initiated by removing a microvascular
clamp. Liver biopsies from the left lateral lobe were collected at 40 min of reperfusion and
immediately frozen in liquid nitrogen.
2.10. Confocal and Multiphoton Microscopy
Confocal images of TMRM, calcein, and PI were collected using an inverted Zeiss
510 laser scanning confocal microscope [7]. Briefly, hepatocytes were incubated with 1 µM
calcein/AM, 500 nM TMRM, and 30 µM PI to visualize MPT, mitochondrial membrane
potential, and cell death, respectively. For intravital liver images, livers were labeled with
Rd-123 (10 µM), as previously described [20]. After 40 min of reperfusion in vivo, the
liver was placed over a glass coverslip on the stage of a Zeiss LSM510 equipped with a
multiphoton microscope (Coherent Inc., Santa Clara, CA, USA). Images were collected
with a 40 × water-immersion objective lens with an excitation of 780 nm. Fifteen to twenty
images were randomly collected per liver. The relative fluorescence intensity of TMRM
and Rd-123 was calculated using histogram analysis in Adobe Photoshop CS4 software
(Adobe Systems, San Jose, CA, USA).
2.11. Statistical Analysis
Differences between means were compared by the Student’s t-test and the Mann–Whitney
test using a level of significance of p < 0.05. Data were expressed as means ± standard error.
Results were representative of at least three independent experiments.
3. Results
3.1. Loss of CAST after I/R in Aged Livers
To examine whether aging alters CAST after I/R in human livers, non-tumorous
specimens were collected from the patients who underwent liver resection. Six independent
liver specimens from the male (M) and the female (F) patients at different ages were
collected before and after 15 min of one episode of inflow occlusion, followed by 5 and
15 min after reperfusion (Figure 1A and Supplemental Table S1). Immunoblot (IB) analysis
showed that CAST expression after 15 min of reperfusion was substantially lower than
basal values (0 min of ischemia) in aged livers (64–73 years old), but not in young livers
(25–40 years old). To test whether this age-dependent loss in CAST occurs in mice after I/R,
we subjected livers from young (3-month-old) and aged (26-month-old) male C57 BL/6 J
mice to 30 min of in vivo ischemia followed by 40 min of reperfusion (Figure 1B) [2,11].
Similar to human livers, in vivo I/R markedly decreased CAST only in aged livers. Next,
hepatocytes were isolated from young and aged mice and exposed to 2 h of in vitro
simulated ischemia, a mild ischemia causing minimal injury in young hepatocytes [20].
IB showed a progressive loss of CAST during I/R in aged cells (Figure 1C). After 60 min
of reperfusion, CAST declined to 5% of basal levels, which did not occur to young cells.
These data suggest that mild I/R depletes aged hepatocytes of CAST.
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3.3. Cytoprotection by CAST Overexpression
We next explored whether CAST depletion contributes to age-dependent cell death
after reperfusion. We overexpressed CAST in aged hepatocytes with the adenovirus encod-
ing cyan fluorescent protein (CFP)-tagged CAST (AdCAST-CFP). Adenovirus expressing
CFP (AdCFP) was used for a viral control. CAST overexpression was confirmed by the
appearance of the upper CAST band with slower mobility due to the presence of the
CFP tag (Figure 3A). Subcellular fractionation assay indicated that both endogenous and
exogenous CAST were localized predominantly in the cytosol (Figure 3B), consistent with
previous reports [19,21]. Importantly, CAST overexpression significantly attenuated cell
death in aged hepatocytes after I/R, implying a causative role of CAST loss in heightened
I/R injury (Figure 3C). Similar to endogenous CAST, CAST-CFP progressively decreased
after reperfusion, suggesting the presence of intrinsic cellular events causing CAST loss.
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3.4. Blockade of the MPT by CAST Overexpression
The onset of MPT is a cardinal event contributing to hepatocyte death after reperfu-
sion [22,23]. We, therefore, sought to examine whether CAST overexpression can block
the MPT. Laser scanning confocal microscopy was used to visualize the mitochondrial
membrane potential (∆Ψm), MPT, and necrosis using TMRM, calcein, and PI, respectively
(Figure 3D) [7,20]. Calcein is a green fluorescent dye with a molecular weight of 622.5 Da
that is impermeable to polarized mitochondrial inner membranes. As a result, confocal im-
ages of calcein-loaded hepatocytes display a honeycomb appearance with dark round voids
corresponding to individual polarized mitochondria that have not undergone the MPT.
TMRM is a red fluorophore that electrophoretically accumulates in polarized mitochondria.
PI labels nuclei of necrotic cells. After 2 h of ischemia, TMRM fluorescence was barely
detectable due to anoxic depolarization in mitochondria while simultaneously excluding
green fluorescent calcein, indicating a lack of the MPT during ischemia. Upon reperfusion,
mitochondria transiently repolarized within 3 min. However, after 11 min, mitochondria
began losing TMRM fluorescence and underwent the MPT, as evidenced by the redistri-
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bution of calcein from the cytosol to mitochondria (disappearance of dark voids). After
14 min, calcein fluorescence vanished and cell death ensued due to the rupture of plasma
membranes, as shown by nuclear labeling of PI (arrows). In sharp contrast, MPT onset and
cell death were blocked by CAST overexpression (Figure 3E), demonstrating that CAST
overexpression prevents the MPT, mitochondrial depolarization, and necrosis in reperfused
aged hepatocytes. Noticeably, a few mitochondria had elongated morphology with CAST
overexpression, suggesting that CAST affects mitochondrial shape (yellow squares).
3.5. Restoration of Autophagy by CAST Overexpression
Timely removal of aberrant mitochondria through autophagy is critical for cell sur-
vival. We have reported that reperfused aged hepatocytes have defective autophagy,
leading to the development of MPT, mitochondrial failure, and, ultimately, necrosis [2,3].
Mitochondrial dysfunction after I/R can be mitigated by stimulating autophagy prior
to the commencement of ischemia [2,20,24]. Accordingly, we investigated how CAST
overexpression influences autophagy. Autophagic flux was determined biochemically
using a lysosomal inhibitor, CQ (Figure 4A,B) [25,26]. The difference in the amount of
LC3-II before and after CQ represents the net amount of autophagic cargo delivered to
lysosomes [2]. Similar to previous results [2], aged cells lost autophagic flux after I/R
whereas young cells sustained the flux. In aged cells, CAST overexpression not only
restored autophagic flux after reperfusion but substantially enhanced the basal level of
autophagy. On the contrary, CAST overexpression in young cells did not affect the flux
before and during I/R. The importance of CAST in mitochondrial integrity and autophagy
was also confirmed by transmission electron microscopy (TEM) (Figure 4C). After 30 min
of reperfusion, CAST overexpression prevented structural distortion of mitochondria and
promoted the formation of autophagic vesicles (yellow arrows). To directly visualize the
onset of mitophagy, confocal images were collected after labeling aged cells with GFP-LC3,
TMRM, and PI [2,11,20,24]. Control cells at 30 min after reperfusion displayed weak TMRM
fluorescence and only a few autophagosomes (Figure 4D). The other cell had lost viability
(yellow arrow). In clear contrast, the mitochondria with CAST overexpression remained
polarized, many of which were surrounded by autophagosomes (white arrows), indicative
of mitophagy onset [2,11]. Moreover, polarized mitochondria had both elongated and oval
shapes. However, only the latter appeared to undergo mitophagy, implying the importance
of mitochondrial size and shape in the onset of mitophagy. Together, our results firmly sug-
gest that CAST is involved in sustaining autophagy, ∆Ψm, and survivability in reperfused
aged cells.
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Figure 4. Restoration of autophagic flux in reperfused aged hepatocytes by CAST overexpression.
Autophagic flux after 2 h of ischemia in young (A) and aged (B) hepatocytes with and without CAST
overexpression (n = 5). Autophagic flux was measured by IB of LC3-II levels in the presence or
absence of 20 µM CQ. Graph repr sents the quantification of LC3-II relative to its level at r i
it i ages in reperfused aged hepatocytes with and without CAST overexpression.
Yellow arrows indicate autophagic vehicl s. (D) Representative confocal images of GFP-LC3 and
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3.6. Mitochondrial Fusion by CAST Overexpression 
Mitochondria are highly dynamic organelles that continuously fuse and divide [28]. 
The balance between fusion and fission determines mitochondrial shape. In mammalian 
cells, fusion is governed by mitofusin (MFN) and optic atrophy 1 (OPA1) in mitochondrial 
outer and inner membranes, respectively, while fission is primarily mediated by dy-
namin-related protein 1 (DRP1) and fission-1-protein (FIS1) [28]. Like mitophagy, mito-
chondrial dynamics (MD) also plays a pivotal role in mitochondrial quality control. Ac-
cordingly, we analyzed MD proteins after I/R (Figure 6A). The basal expression of DRP1 
was noticeably lower in aged hepatocytes than in young cells, although a statistical sig-
nificance was not reached. Other MD proteins including MFN1, MFN2, and OPA1 were 
comparable between the two age groups. I/R significantly diminished MFN1 and 2 and 
DRP1 in aged cells. We observed that the short form of OPA1 (S-OPA1), a fission inducer 
[29–32], was increased in reperfused aged cells, whereas the long form of OPA1 (L-OPA1), 
a fusion inducer, was decreased after prolonged reperfusion, suggesting a shift of MD in 
reperfused aged cells. IB analysis of five unique OPA1 bands further revealed that I/R 
significantly enhanced the cleavage of L-OPA1 (band a and b) to S-OPA1 (band c and e), 
i .
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of ATGs relative to their levels at normoxia without CAST overexpression. (B) Effects of CAST
overexpression on autophagy induction under starvation conditions (n = 4). Changes in LC3-II were
expressed relative to its level at 0 h without CAST overexpression. (C) Confocal images of GFP-LC3
and TMRM in aged hepatocytes after 2 h of starvation with (bottom panels) and without CAST
overexpression (top panels). (D) IB analysis of ATGs in aged hepatocytes during 2 h of starvation
(n = 3). Changes in individual ATGs were expressed relative to their levels at 0 h without CAST
overexpression. * p < 0.05 and ** p < 0.01.
3.6. Mitochondrial Fusion by CAST Overexpression
Mitochondria are highly dynamic organelles that continuously fuse and divide [28].
The balance between fusion and fission determines mitochondrial shape. In mammalian
cells, fusion is governed by mitofusin (MFN) and optic atrophy 1 (OPA1) in mitochondrial
outer and inner membranes, respectively, while fission is primarily mediated by dynamin-
related protein 1 (DRP1) and fission-1-protein (FIS1) [28]. Like mitophagy, mitochondrial
dynamics (MD) also plays a pivotal role in mitochondrial quality control. Accordingly, we
analyzed MD proteins after I/R (Figure 6A). The basal expression of DRP1 was noticeably
lower in aged hepatocytes than in young cells, although a statistical significance was
not reached. Other MD proteins including MFN1, MFN2, and OPA1 were comparable
between the two age groups. I/R significantly diminished MFN1 and 2 and DRP1 in aged
cells. We observed that the short form of OPA1 (S-OPA1), a fission inducer [29–32], was
increased in reperfused aged cells, whereas the long form of OPA1 (L-OPA1), a fusion
inducer, was decreased after prolonged reperfusion, suggesting a shift of MD in reperfused
aged cells. IB analysis of five unique OPA1 bands further revealed that I/R significantly
enhanced the cleavage of L-OPA1 (band a and b) to S-OPA1 (band c and e), which was,
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however, suppressed by CAST overexpression. No other MD proteins were changed by
AdCAST-CFP (data not shown). Altered mitochondrial shape by CAST was also confirmed
by TMRM confocal microscopy (Figure 6C). Following CAST overexpression, aged cells
had numerous interconnected mitochondria, supporting that CAST shifts the balance of
MD toward fusion. Relative TMRM fluorescence intensity was similar before and after
AdCAST-CFP treatment (47.5 ± 14. 8 vs. 60.43 ± 22.5), indicating minimal alterations
in ∆Ψm by CAST overexpression. Overall, these results suggest that CAST impacts both
autophagy and mitochondrial fusion, two integral processes involved in mitochondrial
quality control.
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3.7. Cytoprotection of Aged Livers by CAST Overexpression after In Vivo I/R
An adenoviral vector harboring CAST with an α1-antitrypsin promoter (AdCASTLV)
facilitates the liver-specific delivery of CAST [33–36]. Some aged animals were intraperi-
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toneally injected with this viral vector before the commencement of ischemia. IB analysis
with the same animals showed that CAST was predominantly overexpressed in the liver
with a minor increase in the kidney (Figure 7A). This viral vector did not affect the ex-
pression of CAST in skeletal muscles, hearts, and spleens. To extend our findings from
hepatocytes to livers, young and aged mice were subjected to 70% partial hepatic ischemia
by clamping the portal triad for 30 min. Compared to young mice, tissue TNFα (IB anal-
ysis) and serum ALT levels (colorimetric determination) after 24 h of reperfusion were
significantly higher in aged mice, substantiating age-dependent I/R injury (Figure 7B,C).
CAST overexpression markedly reduced serum ALT after I/R. Moreover, hepatic TNFα
levels were decreased by AdCASTLV treatment in two out of three aged mice, although
a statistical significance was not reached. To test whether CAST overexpression sup-
presses mitochondrial depolarization, a salient feature of MPT [23], multiphoton images of
rhodamine-123 (Rd-123), a mitochondrial potential indicator [2,37], were collected from
young and aged mouse livers after 40 min of reperfusion (Figure 7D). The liver from a
young mouse displayed numerous green punctae (polarized mitochondria) in hepatocytes.
The aged liver with a control virus, however, exhibited diffuse and weak Rd-123 fluores-
cence, signifying a mitochondrial depolarization and bioenergetic failure [2,38]. The relative
fluorescence intensity of Rd-123 was significantly decreased from 41.5 ± 12.1 (young con-
trol) to 0.9 ± 1.1 (aged control) after reperfusion. In sharp contrast, CAST overexpression
attenuated reperfusion-induced loss in ∆Ψm. Compared to the aged control, the relative
fluorescence intensity of Rd-123 was markedly greater in the AdCASTLV group (0.9 ± 1.1
vs. 28.9 ± 6.3). Altogether, these results support our conclusion that CAST overexpression
is cytoprotective against mitochondrial dysfunction in reperfused aged livers.
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asal e ressi of C ST in aged livers than in young livers. However, when exposed
to short I/R, modest stress inducing minimal injury to young livers, aged livers rapidly
lost CAST, leading to the stimulation of calpains, defective autophagy, accumulation of
dysfunctional mitochondria, and, ultimately, hepatocyte death. The importance of CAST
in the survivability of reperfused aged hepatocytes is supported by our findings; (1) short
and modest I/R depletes aged livers and hepatocytes of CAST, which does not occur in
young counterparts (Figure 1). (2) Despite its higher basal level, CAST in aged livers is
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intrinsically short-lived and rapidly declines after I/R (Figure 2). (3) CAST overexpression
suppresses defective autophagy, MPT onset, mitochondrial depolarization, and cell death
after reperfusion (Figures 3–5). (4) As well as autophagy induction, CAST overexpression
shifts MD toward mitochondrial fusion (Figure 6). (5) CAST overexpression protects aged
livers from in vivo I/R injury (Figure 7). Collectively, our results suggest that CAST is
indispensable for the survival of aged livers after I/R.
Uncontrolled stimulation of calpains incites irreversible tissue injury through the
degradation of key structural and functional proteins. We have reported that Ca2+ over-
loading during I/R over-activates calpains, resulting in defective autophagy and hepatocyte
death [2,11,20,24,39]. Our results here substantiated a causative role of calpains in I/R
injury. Under normal conditions, the over-activation of calpains rarely occurs due to the
presence of CAST. The fact that one CAST blocks four calpains through its binding to
two penta-EF domains and one catalytic cleft of calpains [40,41] raised the question as to
how reperfused hepatocytes could develop calpain-mediated cellular damage even in the
presence of such a powerful endogenous calpain inhibitor. We observed that despite its
higher basal level, CAST in aged livers was short-lived.
CAST depletion during I/R in aged hepatocytes appears to be, at least in part, due to
the activation of calpains and/or proteasomes since calpain and a proteasome inhibitor
recovered CAST during the early stage of reperfusion. While the basal activity of cal-
pains, as assessed by the formation of auto-hydrolyzed fragments (18- to 54-kDa) [24],
was comparable between young and aged cells, a substantial increase in calpain activity
was detected only after reperfusion in aged cells (data not shown). Indeed, aging per se
minimally impacts the viability and functionality of hepatocytes, but a noticeable cellular
injury in aged cells occurs after exposure to stresses [2]. Of note, aged cells lost CAST
after prolonged reperfusion even with calpain and proteasome inhibitors, indicating the
presence of other mechanisms behind CAST depletion after reperfusion. One possible
mechanism could be a distinct status of acetylation/deacetylation of CAST in aged cells.
Compared to young hepatocytes, Sirtuin 1 (SIRT1) expression is significantly lower in aged
cells [39]. Bioinformatic analysis predicts that CAST has 16 acetyl-Lys (K) sites (from K42
to K739) that can be deacetylated by SIRT1 [42]. In the pilot studies with immunoprecipi-
tation experiments, we observed that the ablation of SIRT1 markedly increased levels of
acetylated CAST. A CHX study also revealed that a half-life time of CAST in SIRT1-null
hepatocytes was much shorter than that in wild-type cells (data not shown), implying that
the reduced stability of CAST in aged cells could result from abundant hyperacetylated
CAST. The importance of acetylation status in protein stability has been reported [43,44].
Thus, higher levels of basal CAST in aged cells may represent a compensatory mechanism
that counteracts intrinsically unstable CAST in aged livers.
Functional autophagy is critical for cell survival during I/R [2,11,39]. We showed that
CAST overexpression in aged hepatocytes restored autophagic flux and suppressed cell
death after I/R, confirming an integral role of autophagy in hepatocyte viability after I/R.
CAST overexpression significantly increased the expression of Beclin-1, ATG7, and ATG12-
5 before reperfusion. However, their expressions substantially declined after reperfusion.
It is unknown how reperfused aged cells with lower levels of key autophagy proteins
could efficaciously drive autophagy. Intriguingly, CAST overexpression significantly
reduced tATG5 during I/R. Calpains cleave full-length ATG5 (~33 kDa) at Thr193 into
tATG5 (~24 kDa) that subsequently translocates to mitochondria, leading to a loss in
∆Ψm [17,27]. As a further decline in ∆Ψm worsens a cellular ATP shortage in reperfused
aged hepatocytes, CAST-mediated suppression of tATG5 formation is likely to prevent
additional loss in ∆Ψm, thereby allowing cells to reserve ATP that could be used for the
execution of energy-dependent cellular processes such as autophagy. In line with this
notion, we observed that CAST overexpression prevented tATG5 formation and promoted
autophagy under starvation conditions.
Another interesting finding is that CAST overexpression shifts MD toward fusion.
While cytoprotective, CAST overexpression did not recover MFN1, MFN2, and DRP1 after
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I/R. Among MD proteins, only S-OPA1 expression was profoundly diminished by CAST
overexpression. L-OPA1 induces fusion, whereas S-OPA1 triggers fission [45]. Excessive
conversion of L-OPA1 into S-OPA1 is known to induce tissue injury [46–48]. Under non-
lethal conditions, healthy mitochondria fuse or interconnect with suboptimal mitochondria
to sustain bioenergetic efficiency [12]. This adaptive morphological change rescues 80%
of the mitochondrial DNA abnormalities and increases mitochondrial oxidative phospho-
rylation through sharing individual mitochondrial contents [49,50]. Indeed, strategies
promoting mitochondrial fusion exert cytoprotection against nutrient insufficiency [51],
oxidative stress [52], neurodegeneration [53], cardiac [54] and renal reperfusion injury [55].
Mitochondrial fusion has been proposed to serve as the first line of defense against acute
stress [14]. Suboptimal mitochondrion that fails to fuse with healthy mitochondrion is
eliminated by mitophagy later [14]. As autophagy is a highly energy-consuming pro-
cess [56,57], elevated demand for autophagy becomes an additional burden to energetically
compromised cells. If damaged mitochondria continue to escape the fusion process, the
autophagic burden exceeds the cellular capacity of autophagy. Dysfunctional mitochondria
accumulate and cell death ensues thereafter. Hence, mitochondrial fusion triggered by
CAST appears to be another protective mechanism by which the autophagic and energetic
burden is relieved in hepatocytes.
Numerous synthetic calpain inhibitors have been developed, yet their clinical use is
limited due to a lack of specificity and side effects [58]. The present study suggests that
CAST may be a potential therapeutic target to reduce I/R injury. Despite the development
of a few CAST-based inhibitors such as subdomain B peptide and oligoarginine-conjugated
peptides, their clinical applicability is far from ideal mainly because these peptidomimetic
compounds fail to generate α-helical and β-barrel structures upon their binding to calpains,
key structural motives required for calpain-specific inhibition [59]. Thus, short peptide
sequences in CAST subdomains may not fully mimic the efficacy of CAST, and gene therapy
delivering a full sequence of the CAST gene could be a therapeutic strategy to decrease
I/R injury in aged livers.
In summary, CAST in aged hepatocytes is abundant yet short-lived and becomes
rapidly depleted after I/R. CAST loss after I/R leads to the stimulation of calpains, accu-
mulation of tATG5, impaired autophagy, MPT onset, and hepatocyte death, all of which are
suppressed by CAST overexpression. Moreover, CAST shifts mitochondrial morphology
toward an elongated shape in order to sustain hepatocyte viability after I/R. These findings
suggest that CAST may be a therapeutic target to ameliorate I/R injury in elderly patients
undergoing liver surgery.
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